Abstract
In this issue of Blood, Pedrazzini et al1 have taken an important step toward revitalizing our view of coronary artery thrombosis and providing a new target for the pharmacologic treatment of acute coronary syndromes (ACS).
Original language | English (US) |
---|---|
Pages (from-to) | 2788-2789 |
Number of pages | 2 |
Journal | Blood |
Volume | 127 |
Issue number | 23 |
DOIs |
|
State | Published - Jun 9 2016 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology